TITLE

U.S. employers embrace European Rx model

AUTHOR(S)
Elswick, Jill
PUB. DATE
May 2005
SOURCE
Employee Benefit News;5/1/2005, Vol. 19 Issue 6, p17
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the reference-based pricing approach used by employers to drive health plan participants toward less expensive medications in the U.S., as of May 2005. Outcome of the implementation of reference pricing by WellPoint; Methods used to determine a drug category's reference price; Reasons behind the potential reluctance of pharmacy benefit managers to embrace reference pricing.
ACCESSION #
16945614

 

Related Articles

  • Drug Costs. Klotter, Jule // Townsend Letter for Doctors & Patients;Jul2003, Issue 240, p27 

    Focuses on the impact of the increasing cost of prescription drugs on insurers and employers paying for health benefits in the U.S. Appeal of employers to use less expensive but effective drugs; Use of reference pricing in controlling drug reimbursement costs.

  • VIEW.  // Employee Benefit News;Sep2015, Vol. 29 Issue 12, p6 

    The article offers employee benefit news briefs as of September 15, 2015 including the suggestions offered by blogger and author Sharlyn Lauby for employers on hiring remote workers, the solutions in managing specialty drug spending and the employee questions on private exchange enrollment.

  • STUDY REVEALS SIGNIFICANT INCREASE IN EMPLOYEE HEALTH, DRUG AND DISABILITY COSTS.  // HR Professional;Sep2013, Vol. 30 Issue 6, p15 

    The article reports on the results of the research study "Banking on productivity: Managing employee health costs," by the Canadian Financial Executives and sponsored by Canadian's consulting and outsourcing company Morneau Shepell. The study shows several factors for the increasing costs of...

  • Managing the drug dilemma. Santiago, Raquel // Crain's Cleveland Business;7/23/2001, Vol. 22 Issue 30, p18 

    Reports that managed care companies and employers in Northeast Ohio are trying to make their enrollees more price conscious by informing employees about drug costs and lower-priced generics. Changes in prescription coverage plans; SummaCare Health Plan Inc.'s implementation of additional...

  • Attention all shoppers: How to be a smart PBM shopper. Kraft, Emil B. // Employee Benefit News;Aug2008, Vol. 22 Issue 10, p40 

    The article offers tips on how to become a smart shopper of pharmacy benefit management (PBM). It stresses the need for employers purchasing pharmacy benefits to consider the total cost of the benefit management. Also cited are the reasons behind the inefficiency of PBM procurement that focuses...

  • How to alleviate specialty Rx costs. WINN, MELISSA A. // Employee Benefit Adviser;Oct2014, Vol. 12 Issue 10, p44 

    The article discusses the critical role of benefit advisers in helping employers form strategies to manage the costs of their medical plans, since employers continue to struggle in their health costs because of increasing specialty drug costs. Topics covered include the importance of including...

  • You can't manage what you can't measure. MOTHERAL, BRENDA R.; FAIRMAN, KATHLEEN // Employee Benefit News;Dec2013, Vol. 27 Issue 15, p13 

    The article discusses considerations in managing specialty medications and spending, focusing on the need for employers to raise their awareness on specialty drug spend paid by the medical benefit and specialty medical cost trends. It discusses key areas that should be addressed by employers...

  • Prescriptions for Employers' Drug Costs. Miller, Stephen // HR Magazine;Aug2008, Vol. 53 Issue 8, p82 

    The article focuses on drug costs for employers. Cost increases for pharmacy benefits still outpace increases for employee medical coverage overall, but the gap has been shrinking, mainly because employers have been adopting tactics designed to better manage their prescription drug costs. Most...

  • Drug plan tiers rise to address specialty drugs. STOLZ, RICHARD // Employee Benefit News;Sep2015, Vol. 29 Issue 11, p12 

    The article reports that numerous employers in the U.S. have added drug-plan pricing tiers to their drug program designs as of September 2015. The move is attributed to various factors which includes the increase in health benefit expenses due to the high cost of drugs including specialty drugs....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics